Hemant Surgical Industries (BOM:543916) EBIT : ₹138 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hemant Surgical Industries EBIT?

Hemant Surgical Industries's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2024 was ₹52 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹138 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Hemant Surgical Industries's annualized ROC % for the quarter that ended in Sep. 2024 was 5.87%. Hemant Surgical Industries's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 25.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Hemant Surgical Industries's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 11.32%.

Hemant Surgical Industries EBIT Historical Data

The historical data trend for Hemant Surgical Industries's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemant Surgical Industries EBIT Chart

Hemant Surgical Industries Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

EBIT

33.22

77.20

120.46

137.53

Hemant Surgical Industries Semi-Annual Data
	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EBIT	Get a 7-Day Free Trial			48.39	72.07	52.49	85.04	52.48

Competitive Comparison of Hemant Surgical Industries's EBIT

For the Medical Devices subindustry, Hemant Surgical Industries's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemant Surgical Industries's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hemant Surgical Industries's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hemant Surgical Industries's EV-to-EBIT falls into.

Save

Hemant Surgical Industries EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹138 Mil.

Hemant Surgical Industries (BOM:543916) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Hemant Surgical Industries's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	56.798 * ( 1 - 28.93% )	/	( (563.622	+	812.708)	/ 2 )
=	40.3663386	/	688.165
=	5.87 %

where

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	966.372	-	271.044	-	( 131.706	-	max(0, 377.919	-	692.961	+	131.706	))
=	563.622

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1159.43	-	268.486	-	( 78.236	-	max(0, 476.629	-	769.225	+	78.236	))
=	812.708

Note: The Operating Income data used here is two times the semi-annual (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Hemant Surgical Industries's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	104.964	/	( ( (176.62 + max(215.444, 0))	+	(332.655 + max(108.575, 0)) )	/	2 )
=	104.964	/	( ( 392.064	+	441.23 )	/	2 )
=	104.964	/	416.647
=	25.19 %

where Working Capital is:

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(217.366	+	210.503	+	133.386)	-	(271.044	+	0	+	74.767)
=	215.444

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(184.574	+	308.252	+	43.081)	-	(268.486	+	0	+	158.846)
=	108.575

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Hemant Surgical Industries's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	137.52	/	1214.687
	=	11.32 %

Hemant Surgical Industries EBIT Related Terms

Thank you for viewing the detailed overview of Hemant Surgical Industries's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemant Surgical Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hemant Surgical Industries Ltd (BOM:543916) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

J.S.D. Road, 502, 5th Floor, Ecstasy Business Park, Co-Op Society Limited, Mulund West, Mumbai, MH, IND, 400 080

Website

https://www.hemantsurgical.com

Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.

Hemant Surgical Industries Headlines

No Headlines